Chemical Component Summary

NameMasitinib
Identifiers4-[(4-methylpiperazin-1-yl)methyl]-~{N}-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide
FormulaC28 H30 N6 O S
Molecular Weight498.64
TypeNON-POLYMER
Isomeric SMILESCc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C
InChIInChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)
InChIKeyWJEOLQLKVOPQFV-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count66
Chiral Atom Count0
Bond Count70
Aromatic Bond Count23

Drug Info: DrugBank

DrugBank IDDB11526 
NameMasitinib
Groups
  • investigational
  • vet_approved
DescriptionMasitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in dogs. It has been available in Europe since 2009, under the brand name Masivet. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.
Synonyms
  • Masitinib mesylate
  • Masitinib
Categories
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Protein Kinase Inhibitors
  • Sulfur Compounds
ATC-CodeL01XE22
CAS number790299-79-5

Related Resource References

Resource NameReference
PubChem10074640
ChEBICHEBI:63450
ChEMBLCHEMBL1908391
PharosCHEMBL1908391